Latest Updates
-
Aja Ekadashi 2026: 6th Or 7th September? Know The Correct Date, Vrat Katha, Tithi And Rituals -
PCOS Is Getting Younger: Why More Teenagers Are Being Diagnosed Than Ever Before -
National Nutrition Week 2026: What To Eat To How To Eat — Expert Shares 7 Ayurveda Rules For Mindful Nutrition -
Kareena Kapoor's Power Dressing At ‘Daayra’ Trailer Launch: 6 Bollywood Actresses Who Owned The Blazer Trend -
Dahi Handi 2026: Why Govindas Form Human Pyramids And What The Tradition Really Means -
Teachers Day 2026: 7 Things Students Can Teach Their Teachers In Return -
Happy Teacher's Day 2026: 100+ Wishes, Messages, and Captions To Say Thank You -
Teachers’ Day 2026: Dr Sarvepalli Radhakrishnan's Story And Why We Celebrate His Birthday -
New OTT Releases This Week (31 Aug-6 Sept): What To Watch Across Netflix, JioHotstar, Prime Video And SonyLiv -
Happy Janmashtami Wishes 2026: 50+ Quotes, Captions, Posts For Instagram, Facebook, WhatsApp And X
Study Links Obesity, T2DM, And Neurodegeneration

A new study has found that obesity and Type 2 Diabetes Mellitus (T2DM) can contribute to mild neurodegeneration with features common with Alzheimer's disease (AD).
Researchers at Rhode Island Hospital say their study is the first one to show that obesity can cause neurodegeneration.
In a study on animal models, lead author Suzanne de la Monte, MD, MPH, of Rhode Island Hospital, utilized chronic high fat diets to cause a two-fold increase in mean body weight.
In these models, there was a marginally reduced mean brain weight and a significantly reduced mean brain weight/body weight ratio, providing evidence that obesity with T2DM is sufficient to cause mild global atrophy in the brain.
"In essence, the brain shrinks and several biochemical and molecular abnormalities found in patients with AD, including brain insulin resistance, develop with chronic obesity and T2DM. However, the extent of the abnormalities in no way matches AD."
It is found that the neuropathological abnormalities were mild and the associated brain insulin resistance could serve as a co-factor in the development and progression of AD.
Overall, the study showed that that the effects of obesity and T2DM can essentially aggravate or contribute to the severity or progression of AD, but cannot be the sole cause of the condition.
The findings suggest that strategies to reduce obesity and prevent or control T2DM could modify the clinical course of mild cognitive impairment and AD.
"We don't know yet if these effects of T2DM/obesity are reversible with weight loss. However, we're fairly sure that the abnormalities are related to the T2DM that accompanies obesity and not just increased weight," De la Monte said.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications